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Comparative structural analysis of the caspase family with other clan CD
cysteine peptidases
Karen McLuskey*1 and Jeremy C. Mottram*1
*Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow,
Glasgow G12 8TA, UK
Clan CD forms a structural group of cysteine peptidases,
containing seven individual families and two subfamilies of
structurally related enzymes. Historically, it is most notable for
containing the mammalian caspases, on which the structures of the
clan were founded. Interestingly, the caspase family is split into
two subfamilies: the caspases, and a second subfamily containing
both the paracaspases and the metacaspases. Structural data are
now available for both the paracaspases and the metacaspases,
allowing a comprehensive structural analysis of the entire caspase
family. In addition, a relative plethora of structural data has
recently become available for many of the other families in
the clan, allowing both the structures and the structure–function
relationships of clan CD to be fully explored. The present review
compares the enzymes in the caspase subfamilies with each other,
together with a comprehensive comparison of all the structural
families in clan CD. This reveals a diverse group of structures with
highly conserved structural elements that provide the peptidases
with a variety of substrate specificities and activation mechanisms.
It also reveals conserved structural elements involved in substrate
binding, and potential autoinhibitory functions, throughout the
clan, and confirms that the metacaspases are structurally diverse
from the caspases (and paracaspases), suggesting that they should
form a distinct family of clan CD peptidases.
Key words: caspase, clan CD, crystallography, metacaspase,
peptidase, protein structure.
INTRODUCTION
Clan CD [1] cysteine peptidases use an active site cysteine
residue to catalyse the hydrolysis, and subsequent cleavage, of
peptide bonds in proteins. These peptidases generally show a strict
specificity for the P1 residue of their substrates and depend only on
two key catalytic residues: a highly conserved histidine/cysteine
dyad. In clan CD, the order, type and surrounding tertiary
structure of the dyad are used to assign enzymes to the
clan [2].
The founding member of clan CD was discovered in 1994 by the
determination of the 3D crystal structure of human interleukin-1β-
converting enzyme [3,4], also known as caspase-1. This structure
revealed a novel protein fold and was consequently placed in
a new structural group of cysteine peptidases (clan CD [5]) as
family C14, which is often referred to as the caspase family.
Since its discovery, clan CD has been expanded to include
seven peptidase families: clostripains (C11); legumains (C13);
caspases (C14); gingipains (C25); separases (C50); the cysteine
peptidase domain (CPD) of the multi-functional, autoprocessing
repeats in toxin (MARTX) toxins (C80); and most recently the
enzymes related to the peptidase virulence factor PrtH from
Tannerella forsythia [6] (C85). Notably, family C14 is further
divided to contain subfamilies C14A (the caspases) and C14B
{both the metacaspases and the paracaspases [denoted C14B(M)
and C14B(P), respectively]}. The phylogenetic distribution of
the clan CD peptidases spans all the kingdoms of life (Table 1).
However, the caspase family (C14) is the only family that has
been identified in all kingdoms, although each subfamily is found
only in certain branches [7] (Table 1).
Since the structural determination of caspase-1, approximately
170 caspase structures have been deposited in the Protein Data
Bank (PDB [8], www.rcsb.org) with around 30 of them assumed
to be unique (<90% sequence identity). In addition, X-ray
crystal structures are also available for families C11 (unpublished,
PDB ID 3UWS), C13 [9], C14B(P) [10], C14B(M) [11,12], C25
[13,14] and C80 [15–17]. Apart from the original structure of
gingipain R [13] (RgpB, C25), all these structures have been
determined within the last 6 years (Table 1), making it an exciting
time to analyse this diverse and structurally expanding clan. The
present review summarizes the collective structural information
of the families, evaluates and compares the structure–function
relationships, and allows for greater understanding of the enzymes
in clan CD.
FAMILY C14: CASPASES, METACASPASES AND PARACASPASES
Caspases
The name caspase is an abbreviation of cysteine-dependent,
aspartate-specific peptidase, because caspases have a dominant
specificity for protein substrates that contain an aspartate in
the P1 position (Table 2). Functionally, the caspases are major
regulators of apoptotic cell death pathways, proliferation and
inflammation, playing vital roles in the life and death of animal
Abbreviations: AP, activation peptide; CARD, caspase recruitment domain; CHF, caspase/haemoglobinase fold; CPD, cysteine peptidase domain;
CSD, C-terminal subdomain; DD, death domain; DED, death effector domain; InsP6, myo-inositol hexakisphosphate; LSAM, legumain stabilization and
activity modulation; LSD1, lesion-simulating disease 1; MALT1, mucosa-associated lymphoid tissue translocation protein 1; MARTX, multi-functional,
autoprocessing repeat in toxin; RMSD, root-mean-square deviation; SSE, secondary structural element; XIAP, X-linked inhibitor of apoptosis; Z-VRPR-
FMK, benzoxycarbonyl-Val-Arg-Pro-Arg-fluoromethylketone.
1 To whom correspondence should be addressed (email Karen.McLuskey@me.com or Jeremy.Mottram@glasgow.ac.uk).
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Table 1 The structural availability and phylogenetic distribution of the clan CD families
The availability () and absence (×) of clan CD families in the phylogenetic kingdom. The year that the first structure became available is shown for each family (year).
FAMILY Representative member Structural data? (year) Bacteria Achaea Protozoa Fungi Plants Viruses Animals
C11 Clostripain Yes (2013)    ×  × ×
C13 Legumain Yes (2013)      × 
C14A Caspase Yes (1994) × × × × ×  
C14B(P) Paracaspase Yes (2011)   × × × × 
C14B(M) Metacaspase Yes (2012)      × ×
C25 Gingipain R Yes (1999)   × × × × ×
C50 Separase No × ×    × 
C80 MARTX-CPD Yes (2008)  × × × × × 
C84 PrtH peptidase No  × × × × × ×
Clan CD       
Table 2 Enzymatic properties of the clan CD peptidases
Family Representative member Specificity in P1 Requirement for activation Self-inhibition observed? Region of self-inhibition
C11 Clostripain Arginine Ca2 + Unknown –
C13 Legumain Asparagine and aspartate* Change in pH Yes C-terminal domain
C14A Caspase Aspartate Dimerization or proteolysis† Unclear‡ N-terminal region
C14B(P) Paracaspase Arginine Dimerization Yes Substrate-binding loop (L5)
C14B(M) Metacaspase Arginine and lysine§ Ca2 + and/or proteolysis‖ Yes N-terminal region
C25 Gingipain R Arginine or lysine¶ Proteolysis and/or Ca2 + ** Yes N-terminal prodomain
C50 Separase Arginine Ca2 + Unknown –
C80 MARTX-CPD Leucine Ligand binding Yes N-terminal region
C84 PrtH peptidase Arginine Unknown Unknown –
*Legumain will accept asparagine or aspartate residues depending on the pH.
**Cleavage of the proform of gingipain is required for full activation of the enzyme and while Ca2+ is not reported as a prerequisite for activation, all active forms appear to have Ca2+ present.
†Caspases are activated by dimerization or proteolysis depending on the type; typically initiator caspases are activated by dimerization whereas the effector caspases are activated by cleavage
(proteolysis).
‡Self-inhibition using the N-terminal region has been suggested in the effector caspases but there are no structural data to date.
§Metacaspases are known to accept arginine and lysine in P1.
‖Type I metacaspases generally activated by Ca2 + ; this is also true for type II metacaspases but, in addition, proteolysis has also been shown to be important in some cases.
¶Gingipain will accept arginine or lysine depending on the enzyme (gingipain R and K have a strict specificities for arginine and lysine, respectively).
cells. In humans, 11 caspases have been identified (caspase-
1 to caspase-10 and caspase-14) and can be grouped together
according to their sequence similarities [18], which are generally
associated with their involvement in specific cellular processes
[19]. They can (perhaps oversimply) be classified as either
inflammatory (caspase-1, -4 and -5) or apoptotic caspases,
with the latter being further organized into initiator (caspase-
2, -8, -9 and -10) and effector (or executioner; caspase-3, -
6 and -7) caspases [20]. Typically, caspases are described as
having an N-terminal prodomain, which contains an aspartate
site for (auto)proteolysis and varies in length depending on the
type of caspase. The effector caspases have short prodomains
(approximately 25 residues), whereas both the inflammatory and
the initiator caspases have long prodomains (approximately 100–
200 residues), which contain either CARD (caspase recruitment
domain – inflammatory and initiator caspases) or DED (death
effector domain – initiator caspases) motifs [19].
In contrast to their diverse N-terminal regions, the catalytic
domain of the caspases has a virtually identical fold in all
the crystal structures determined to date. However, in order
to describe the structure of the caspases in detail, the well-
studied effector caspase, caspase-7 [21], has been chosen as a
general representative of the caspases in the present review. The
structure of the caspases is formed around a central six-stranded
β-sheet (β1–β6), consisting of five parallel and one antiparallel β-
strand(s) with 2↑1↑3↑4↑5↑6↓ topology [22]. The central sheet is
surrounded by five major α-helices (α1–α5), contains a small
three-stranded section of β-sheet situated between β3 and α3, and
the residues constituting the catalytic histidine/cysteine dyad are
found at the C-terminal ends of strands β3 and β4, respectively.
This basic monomeric fold led to the identification of the other
clan CD members and the description of a minimal core structural
unit, the caspase/haemoglobinase fold (CHF) [23], which is
described as consisting of the first four strands of the β-sheet
(2↑1↑3↑4↑) along with helices α1–α3 (Figure 1A).
A highly conserved proteolytic aspartate is found situated
between strands β4 and β5 of the caspases. As a result, the
original caspase structures were described as having a large (α or
p20) and a small (β or p10) subunit, comprising strands 1–4 and
5–6, respectively, linked together by an inter-subunit linker [4] (a
cleaved loop region). This description of two individual caspase
subunits predated any 3D structural information [24], although
the term ‘inter-subunit linker’ was most probably introduced later.
In reality, caspase monomers do not contain individual subunits
but are simply composed of a single polypeptide chain, which
folds into a central six-stranded β-sheet with a highly conserved
cleavage site. In addition, because of the abundance of caspase
structures available in the literature, other important loop regions
have been named in various ways. Therefore, to standardize the
nomenclature used in the present review, and to allow structural
comparisons with other families in the clan, all terms referring to
caspase subunits are omitted and the loop (L) regions are named
according to the strands that they follow (L1–L5, respectively)
(Figure 1A). Consequently, the substrate-binding loop regions
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Figure 1 The topology and structure of the caspase dimer
Caspase-7 (PDB ID 1F1J, see Supplementary Table S1) is used to represent a typical caspase with all β-strands coloured blue and α-helices grey. Structural elements from the second monomer in
the dimer are coloured paler than the first. (A) The topology and simplified nomenclature of the caspases. The central β-strands and major α-helices are named from the N-terminus (β1–β6 and
α1–α5, respectively); the important loop regions (L) are named according to the strands that they follow (L1–L5); and the small sections of β-turns on L3 and L5 are named β1–β3 and β1–β2,
respectively. The position of the catalytic dyad histidine (H) and cysteine (C) is highlighted in red on L3 and L4, respectively, and the position of the conserved aspartate cleavage site (D) is shown
on L4 (/). A vertical dashed line represents the dimer interface and the C-terminus of the second monomer is shown (′). The CHF SSEs are highlighted (*). (B) Ribbon diagram of a caspase dimer.
Topdraw [90] and PyMOL (http://pymol.sourceforge.net, Schrodinger) were used for topology diagrams and molecular images throughout the present review, respectively.
in the caspases that have been historically known as the 179
loop, inter-subunit linker, 341 loop and 381 loop (caspase-1
nomenclature [18]) or L1, L2, L3 and L4 (caspase-7 nomenclature
[25]) are simply referred to as loops L1, L4, L5 and L5(L5 after
α5), respectively (Figure 1A).
Many caspase structures have been determined complexed with
an inhibitor bound in the active site, and analysis of such structures
allows the hydrogen bond interactions and hydrophobic contacts
to the bound inhibitor to be identified (using LigPlot + [26],
see Supplementary Figure S1). Correspondingly, the structure
of caspase-7 in complex with the inhibitor acetyl-Asp-Glu-
Val-Asp-aldehyde [21] (Ac-DEVD-CHO, see Supplementary
Table S1) reveals that there are a total of five residues
responsible for hydrogen bonding to the P1 aspartate on the
inhibitor: Arg87, Gly145, Gln184, Ser231 and Arg233. Mapping
these residues on to the corresponding regions in the structure,
using the PyMOL molecular graphics system, version 1.2r3pre
(http://pymol.sourceforge.net, Schrodinger) reveals that they are
found on loops L1, L3(β1), L4, L5 and L5(β2), with the
catalytic dyad (His144/Cys186) sitting on L3 and L4, respectively
(Figure 2A). Only the functional groups of Arg87, Gln184 and Arg233
interact with the carboxylic acid side chain of the P1 aspartate,
suggesting that these three residues are collectively responsible for
the specificity of the S1-binding site. Notably, Arg233 (on L5β2)
forms a small section of β-sheet with the bound inhibitor but,
in the absence of inhibitor, this region of active caspase-7 [28]
(see Supplementary Table S1) does not contain any discernible
secondary structure. In addition, several of the effector caspases
can be inhibited by the X-linked inhibitor of apoptosis (XIAP)
family of proteins and, in the case of caspase-7, the interactions
with XIAP closely resemble those between caspase-7 and Ac-
DEVD-CHO (see Supplementary Table S1 [29]).
All known caspases form antiparallel homodimers and, despite
the fact that each monomer contains a catalytic dyad and active
site, dimerization is critical for the stability and formation of a
fully mature caspase. The caspase dimer is formed through β-
strand–β-strand interactions along β6, resulting in an extended
12-stranded β-sheet that is very stable under physiological
conditions [19,30] (see Figure 1). However, depending on the
type of caspase, dimerization occurs at different points in the
activation process [19]. In general, the inflammatory and initiator
caspases are present in cells as monomers and activated by
dimerization, whereas the effector caspases exist in cells as
dimeric zymogens and are activated by intermolecular cleavage
(often by an initiator caspase) at the conserved aspartate in L4.
Activation by cleavage generally results in a large movement in
cleaved L4, creating space, which allows the active site loops to
adopt the correct orientation for activity. Typically, the cleaved
ends of L4 cross the dimer interface and stabilize the substrate-
binding groove in the opposite dimer, without contributing
directly to the opposing active site. It is interesting that activation
of monomeric caspases by dimerization is often followed by a
maturation event such as removal of the prodomain or cleavage
of the L4 loop [20] and, although these events can contribute
to overall stability [31], they are not required for full activation,
because a fully functional active site is formed in their absence.
Activation by dimerization of the initiator and inflammatory
caspases is facilitated by their extended prodomains via an
activation platform, whereby adaptor proteins recognize and bind
the N-terminal recruitment domains (reviewed in Pop and
Salvesen [20]). However, the role of the shorter prodomains found
in the effector caspases is less well defined. Typically, the term
‘prodomain’ refers to a region in an enzyme that must be removed
for, or before, activation. However, in caspase-6 the N-terminal
region was shown to inhibit autoactivation [32] by preventing
intramolecular cleavage on L4 [33], but removal of the region
had an adverse effect on stability and no effect on the enzyme’s
activity against peptide substrates [34]. Similarly, the prodomain
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Figure 2 The S1-binding pockets of the clan CD family members
The catalytic dyad is shown in red and conserved aromatic residues are shown in green. With the exception of TbMCA2, residues that form hydrogen bonds to the P1 residue of a bound inhibitor are
shown in blue (the darker shade of blue represents interactions through functional groups, whereas the lighter blue shows interactions from main chain atoms). Residues and SSEs involved in P1
binding are labelled and SSEs structurally homologous (but topologically diverse) to those found in the caspases are highlighted (H). (A) Caspase-7 PDB (ID 1F1J). (B) Inhibitor-free TbMCA2 (PDB
ID 4AFR) in which residues shown to be important in substrate binding are highlighted in blue, with those responsible for specificity in P1 [11] shown in navy blue. (C) MALT1 paracaspase domain
(MALT1-P) (PDB IB 3UOA). (D) Legumain (PDB ID 4AW9). (E) Gingipain R (PDB ID 1CVR). (F) MARTX-CPD (PDB ID 3GCD). Inhibitors used in complex structures are shown in Supplementary
Table S1.
of caspase-3 was shown to keep the enzyme in a latent form until
its activation by a downstream caspase [35], but removal of the
N-terminal region had no effect on the enzyme’s activity [36].
This also holds true for caspase-7, for which the catalytic activity
of the proform is indistinguishable from that of the wild type
[28] and the cleaved form is reported to be more apoptotically
active [37]. Consequently, in contrast to some other peptidases
(such as the clan CA peptidases, reviewed by Turk et al. [38]),
removal of the effector caspase prodomain is not necessary for
catalytic activity, although it may play an inhibitory role until
enzymatic activity is required. In addition, the N-terminal region
of an effector caspase has so far escaped structural elucidation.
This is despite the fact that both caspase-6 [33] and caspase-7 [28]
(see Supplementary Table S1) have been crystallized as inactive
proenzymes, suggesting that the N-terminal regions do not bind
(tightly) to the surface of the enzymes and are assumed to be
reasonably flexible in solution.
Metacaspases
Given the importance of the caspases in mammals, a search
for orthologues in plants and other non-metazoan organisms
was undertaken by using the primary sequences of caspases, in
and around the active site, in a PSI-BLAST (Position-Specific
Iterative Basic Local Alignment Search Tool) search [39]. This
resulted in the identification of two new groups of peptidases
that were collectively assigned in MEROPS as a new caspase
subfamily (C14B). These peptidases, termed ‘paracaspases’ and
‘metacaspases’, were both found to be present in the genomes
of bacteria and Archaea [40,41]. In addition, the metacaspases
were identified in protozoa, fungi and plants [39], whereas
the paracaspases were found distributed throughout the animal
kingdom, from which the metacaspases were notably absent [42]
(see Table 1).
Early studies on the metacaspases attempted to draw parallels
between possible metacaspase function and the fundamental
and well-established processes carried out by the caspases [43–
46]. Indeed, the yeast metacaspase Yca1 (from Saccharomyces
cerevisiae) has been implicated in cell death processes [43],
suggesting a degree of functional homology with the caspases.
This resulted in similar investigations being carried out on
metacaspases from other organisms, and revealed a role for several
fungi and plant metacaspases in cell death (reviewed in Tsiatsiani
et al. [47]). However, a link with cell death mechanisms could not
be identified for all metacaspases and a number of other functions
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have since been established in various cellular processes including
cell-cycle progression [48], cell proliferation [49], endoplasmic
reticulum (ER) stress [50], clearance of insoluble aggregates [51]
and virulence [52].
Historically, two types of metacaspases have been described
[39] (types I and II), with both types being found in plants
whereas yeast and the protozoa possess only type I. In
addition, a further type of metacaspase (denoted type III) has
recently been described in unicellular photosynthetic algae and
bacteria [40]. It is of interest that the number and type of
metacaspase genes identified in different organisms can vary
considerably [47], although there is insufficient evidence to
indicate whether this shows a degree of functional specialization
or redundancy; both have, however, been reported [44,50,53–
56]. In addition, multi-functional metacaspases have also been
identified, particularly in organisms that have a single metacaspase
gene, e.g. in S. cerevisiae Yca1 [43,48,51] and Leishmania major
LmMCA [57–59].
The original structural classification of all three types of
metacaspases is based on a predicted domain structure originating
from the system adopted for the caspases. This describes
metacaspases as containing large (p20) and small (p10) subunits,
with the addition of other variable structural features such as
an N-terminal prodomain (type I), an extended inter-subunit
linker (type II) and a putative p20/p10 domain swap (type III)
[40]. However, in contrast to the caspases, active metacaspases
show a strict preference for substrates containing basic arginine
and/or lysine residues [46,59–61] (see Table 2). Indeed, this
preference for basic substrates makes the name ‘metacaspase’
technically incorrect. Metacaspases also differ significantly from
the caspases in that they are active monomers [11], for which
activation profiling has revealed a widespread, but not universal
[62], requirement for calcium [45,60,63,64]. In addition, there
are no conserved cleavage sites reported in type I metacaspases,
but this is different for type II metacaspases, which contain
highly conserved cleavage sites that have been shown to play
an important part in the activation mechanism of Arabidopsis
thaliana, AtMC4 and AtMC9 [61,65].
Despite being described as having an N-terminal prodomain,
there is no evidence in the type I metacaspases for removal of
this region for activation. However, several distinct functions have
been attributed to the N-terminal regions in type I metacaspases: in
AtMC1, the N-terminal domain contains a conserved LSD1-like
(lesion-simulating disease 1-like) zinc finger motif, which was
found to interact with LSD1 and negatively regulate its function
[44]; in Yca1, the N-terminal domain is essential for targeting
the enzyme to insoluble aggregates [51] and in Trypanosoma
brucei MCA2 (TbMCA2) the N-terminal region is thought to
act as a gatekeeper, controlling substrate access to the active site
[11]. In addition, stronger autoprocessing has been observed in
AtMC1 and AtMC2 when the N-terminal region is absent [44],
suggesting that, similar to TbMCA2 (and the effector caspases),
this region acts to inhibit/control enzymatic activity until it is
required.
TbMCA2 structure
The structural basis for many of the functional differences
between the metacaspases and caspases was revealed by the
first metacaspase structure, an inactive (C213G/A) mutant of
TbMCA2 [11]. The overall topology of this metacaspase was
rather unexpected, because the structure did not contain the
six-stranded β-sheet found in the caspases. Instead, TbMCA2
contained two extra strands (β7 and β8) sandwiched between
β4 and β5, resulting in a monomeric structure with an eight-
stranded β-sheet of 2↑1↑3↑4↑7↑8↓5↑6↓ topology [22]. Similar to
the caspases, five α-helices and a small section of β-sheet on L3
were found surrounding the central sheet with various loop regions
connecting the secondary structural elements (SSEs) (Figures 3A
and 3B). However, unlike the caspases, the N-terminal region
was extremely well ordered and the 70-residue region preceding
β1 was found to encircle the enzyme and cross over the active
site.
For direct comparison of structures from different clan CD
families throughout the present review, caspase nomenclature is
highlighted for the SSEs and loops of all clan CD structures, when
they are structurally conserved and similar to those found in the
caspases, e.g. β7 in TbMCA2 is structurally homologous to β5 in
the caspases – denoted as Hβ5 (H5; Figure 3B).
Structural determination of a metacaspase in the presence of
a bound substrate and/or inhibitor has so far escaped elucidation
and as a consequence the metacaspase S1-binding pocket cannot
be mapped in the same way as the caspases. However, a
potential S1-binding pocket was described for TbMCA2 and
several residues were shown to be involved in substrate binding
and/or enzyme activity [11]: Cys92, Asp95, Ser156 and Asp211,
which were found on α1, α1, L3 and L4, respectively (see
Figures 2B and 3B). In addition, the L7 (HL5) loop of TbMCA2
was shown to undergo a structural rearrangement at Ala280
(Figure 3B), in the presence of Ca2 + , and is also thought to be
important in substrate binding [11]. The structure of TbMCA2
was determined in the presence of samarium, which facilitated
the identification of an allosteric Ca2 + -binding site comprising
four aspartate residues (Asp173, Asp189, Asp190 and Asp220), which
are highly conserved in a primary sequence alignment of both
type I and type II metacaspases [11]. The PDB identities
for the individual structures are referenced in Supplementary
Table S1.
Yca1 structure
Elucidation of the structure of TbMCA2 was closely followed by
that of the crystal structure of another type I metacaspase from
yeast, Yca1 [12]. Comparing Yca1 with TbMCA2 revealed that
the two structures are very similar, sharing 82% of their SSEs
(PDBeFold [66]), and that the predicted S1- and Ca2 + -binding
sites in TbMCA2 are completely conserved in Yca1, in terms of
both structure and residue type (see Supplementary Figure S2).
Unlike TbMCA2, the structure of Yca1 was determined from
full-length active protein (residues 1–432), although the enzyme
was treated with V8 peptidase before crystallization [12] and,
consequently (or otherwise), the structure of Yca1 contains four
regions with missing residues: the N-terminus (89 residues), the
turn of the β-hairpin on L3 (11 residues), L6 (51 residues) and
L7 (HL5) (11 residues). It is of interest that these regions are
relatively diverse between TbMCA2 and Yca1, with L6 and the
N-terminal region being the most notable (see Supplementary
Figure S2). In TbMCA2, L6 is 8 residues long (and well ordered),
whereas in Yca1 it is 59 residues long and disordered, making L6
a potentially interesting variation between the two enzymes. In
addition, compared with TbMCA2, Yca1 has an extended, non-
conserved, N-terminal region (136 as opposed to 70 residues,
respectively). The first 68 residues of Yca1 consist of QXXQ
repeats involved in targeting Yca1 to insoluble aggregates in
yeast [51] and, although the first 89 residues are absent in the
structure, a further 48 N-terminal residues are found to be ordered.
However, unlike TbMCA2 these residues do not wrap around the
enzyme, but rather are found cradling the base of β5–β8 with
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Figure 3 The structural topologies of the clan CD enzymes
(A) Caspase-7; (B) TbMCA2; (C) MALT1-P; (D); legumain; (E) gingipain R; and (F) MARTX-CPD. The S1-binding pockets are highlighted as in Figure 2 and the topologies are based on the PDB
codes described in the same Figure. Strands in the central β-sheet are numbered from the N-terminus in black. Black numbering is also used for the five major α-helices and important S1-binding
loops (L) when they are located in the structure in the same order as they are in the caspases. SSEs that are structurally homologous to those found in the caspases, but appear in the structure in a
different order, are highlighted with an (H), followed by the caspase numbering, and shown in purple (α and β have been omitted as a result of space constraints but are used in the text). The position
of the catalytic dyad (H/C) is shown in red on loops L3 and L4 (or HL3 and HL4), respectively.
a small β-hairpin section running parallel to the missing region
in L6.
Paracaspases
Paracaspases are the second group of enzymes classified in
the caspase subfamily C14B and, similar to the metacaspases,
these enzymes recognize basic substrates, cleaving after arginine
residues (see Table 2). To date, the only available paracaspase
structures come from the human and murine mucosa-associated
lymphoid tissue translocation protein 1 (MALT1) [10,67].
MALT1 is a large multi-domain protein, which exhibits
functionally important, arginine-specific, proteolytic activity as
a result of its paracaspase domain. The full-length protein
comprises an N-terminal death domain (DD), followed by two
immunoglobin (Ig)-like domains (Ig1 and Ig2), the paracaspase
domain, a further Ig-like domain (Ig3) and approximately 100
C-terminal residues with no apparent secondary structure [10].
The recombinant peptidase appears to be more stable (remains
soluble in solution) in vitro when it is expressed as a complex of
the paracaspase/Ig3 domains [67,68], although the paracaspase
domain alone is active [68].
The original crystal structures of MALT1 were obtained for the
apo-catalytic domain and the paracaspase/Ig3 domains with and
without the peptide inhibitor benzoxycarbonyl-Val-Arg-Pro-Arg-
fluoromethylketone (Z-VRPR-FMK) [10,67] (see Supplementary
Table S1).
The structure of the MALT1 paracaspase domain (MALT1-P)
has a fold virtually identical to that of all known caspases [10]
(see Figure 3C). In addition, MALT1 requires dimerization to
gain activity [67] and the structures both revealed an antiparallel
caspase-like dimer along β6. However, unlike the caspases,
cleavage in L4 is not required for activation and/or maturation of
the enzyme and this is obvious from the inhibitor-bound form
of the structure, which shows L4 to be intact and well ordered.
Conversely, L4 is disordered in the apo-structure, suggesting that
the inhibitor and/or a substrate is required to stabilize this loop.
The structure of MALT1-P with Z-VRPR-FMK reveals that four
residues are involved in hydrogen bonding to the P1 arginine of
the inhibitor: Asp365 (α1), Gly416 (L3), Ala498 (L5) and Glu500 (L5).
In addition, Asp462 (L4) is also found in the S1-binding pocket,
suggesting that Asp365, Glu500 and Asp462 are responsible for the
substrate specificity of MALT1 in P1 (see Figure 2C).
Apart from the ordering of L4, the most striking difference in
the apo- and inhibitor-bound forms of MALT1 is found within
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Table 3 Three-dimensional superposition of clan CD families with caspase 7
The Table is ordered in terms of the quality of the Cα alignment (Q score, QS), in which %SSEQ-C7 is the percentage of the SSEs in the query (Q) that can be identified in caspase-7 (where Q =
MALT1-P, legumain, TbMCA2, PmC11, gingipain R and MARTX-CPD); %SSEC7-Q is the percentage of the SSEs in caspase-7 that can be identified in Q (see above); % Seq. ID is the percentage of
the sequence identity found after structural alignment; Nalign is the number of matched residues; and RMSD is the root-mean-square deviation on the Cα positions of the matched residues.
Enzyme Family PDB ID Q SH %SSEQ-C7 %SSEC7-Q % Seq. ID Nalign RMSD (A˚)
Caspase-7 C14A 1F1J 1.00 100 100 100 230 0.00
MALT1-P C14B(P) 3V4O 0.41 79 73 19 177 1.94
Legumain C13 4AW9 0.34 65 87 13 173 2.05
TbMCA2 C14B(M) 4AFR 0.22 59 67 13 175 2.69
PmC11 C11 3UWS 0.14 38 73 11 151 3.03
Gingipain R C25 1CVR 0.13 32 67 9 161 2.97
MARTX-CPD C60 3GCD 0.10 47 47 6 109 3.60
L5, which undergoes a significant structural rearrangement,
repositioning an important glutamine residue. In the ligand-
free structure, this residue (Gln494) points directly into the S1-
binding pocket, blocking access to the active site. However, in
the inhibitor-bound form L5 points away from the main body of
the enzyme, towards the solvent, and forms an elbow with Gln494
sitting at the tip [69]. This is a substantial shift in Gln494 between
the two structures of approximately 13 Å (1 Å = 0.1 nm) and
approximately 180◦; when the inhibitor is bound L5 forms a small
β-strand–β-strand interaction with the inhibitor, as observed in
caspase-7. The conformation of Ig3 also changes on inhibitor
binding, leading to the suggestion that MALT1 activation is a
two-step process relying on both dimerization and, on substrate
binding, release from Ig3-mediated autoinhibition [69].
Comparison of family C14
As described above, there are two diverse substrate specificities
exhibited within family C14, with the caspases (C14A)
recognizing acidic aspartate residues whereas both the
metacaspases and the paracaspases (C14B) recognize basic
arginine and/or lysine residues (see Table 2). Despite this,
the structure of MALT1-P has much more similarity with the
caspases than the metacaspases. Indeed, the overall topology of
paracaspases and caspases, with six-stranded β-sheets, is virtually
identical [10], forming structurally homologous active dimers (see
Figures 3A and 3C).
To investigate the structural similarities, 3D pair-wise structural
alignments of caspase-7 with MALT1-P and TbMCA2, along with
the alignment of MALT1-P with TbMCA2, were carried out using
PDBeFold [66] (Table 3). This reveals that 79% of the SSEs in
MALT1-P can be identified in caspase-7. In addition, the two
enzymes align with 19% sequence identity: a root-mean-square
deviation (RMSD) of 1.94 on the Cα positions over 177 aligned
residues and a Q score [66] of 0.41. Here, the Q score represents
the quality of the Cα alignment by taking into account both the
RMSD and the alignment length (where a protein matched with
itself will have a Q score of 1) (Table 3).
Superimposing TbMCA2 over caspase-7 revealed that the two
structures align over a similar number of residues to MALT1-
P and caspase-7 (175 with an RMSD of 2.69). However, this
alignment also confirmed that TbMCA2 is much less similar to
the caspases than MALT1-P, for which the SSEs in caspase-7
account for only 59% of the SSEs in TbMCA2, with a much lower
Q score (0.22) and a sequence identity of only 13% (Table 3). The
difference in the metacaspase structure results from the insertion
of the two strands, β7 and β8, which form the extended eight-
stranded β-sheet. This extended β-sheet appears to stabilize the
type I metacaspases as functional monomers, making it impossible
for them to use the same dimerization interface as the caspases and
paracaspases and, in fact, strands β5 and β6 in the metacaspases
are structurally homologous to β5′ and β6′ from the antiparallel
dimer in the paracaspases and caspases (see Figures 1 and 3).
In addition, the metacaspase structures revealed reasonably large
and well-ordered N-terminal regions, which have shown good
association with the main body of the enzyme [11]. This differs
from the caspases, for which the N-terminal region has never been
observed in a crystal structure, suggesting that it is more easily
dissociated.
Both type I metacaspases and the paracaspases differ from
the caspases in that they do not require or exhibit processing
for activity or maturation. However, several type II metacaspases
contain a highly conserved basic (arginine or lysine) residue,
which is critical for activation [61,65]. This cleavage site is found
just before β5 in TbMCA2 at the end of a type II-specific insertion
of approximately 70 residues (after L4). It is also not structurally
homologous to the processing site in the caspases, which occurs
at about 14 residues after β4, as opposed to about 84 residues
in type II metacaspases. This suggests that the mechanism for
type II metacaspases is structurally distinct from both type I
metacaspases and caspases.
Comparing the identified active site regions in caspase-7,
MALT1 and TbMCA2 reveals that, despite the differences
in structure and substrate specificity, they all use structurally
homologous regions for inhibitor/substrate recognition, and that
the catalytic histidine/cysteine dyad resides in the same positions
on the L3 and L4 loops, respectively (see Figure 2). Accordingly,
the conserved regions responsible for inhibitor binding in family
C14 are L1 orα1 (similar spatial region), L3, L4 and L5 (excluding
TbMCA2). In the metacaspases HL5 has not been identified
as contributing to the active site because it is disordered in
both crystal structures. However, a conformational change was
observed in the HL5 loop of TbMCA2 when it was crystallized in
the presence of Ca2 + [11]. Of interest, this loop is also disordered
in both pro-caspase 7 [28] and ligand-free MALT1 [67], but is well
defined in the inhibitor-bound enzymes, suggesting that HL5 will
also be important in the recognition and/or binding of metacaspase
substrates.
The ligand-free structures of both MALT1-P and TbMCA2
revealed that the active sites were blocked sterically, and so
most probably autoinhibited, by a residue on a loop region in
the structures (Gln494 on L5 in MALT1-P and Tyr31 on the N-
terminal region of TbMCA2). In addition, the Ca2 + -induced
conformational change in TbMCA2 at HL5 resulted in this loop
forming a small section of β-sheet with the N-terminus as it
crossed the active site. This is similar to the β-strand–β-strand
interactions observed between L5 and bound inhibitors in both
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Figure 4 The structural diversity in the central β-sheet of the clan CD enzymes
(A) The β-sheet topologies exhibited by the families in the clan. The β-strands described by the CHF [23] are shown in grey whereas the other strands are shown in blue; the N- and C-terminal ends
of the enzymes are labelled accordingly. (B) A phylogenetic tree based on structure, in which Q H [85] is a measure of structural homology. This Figure was produced using a STAMP [87] structural
alignment and VMD [87].
the caspases and MALT1, suggesting that this Ca2 + -induced
loop movement in TbMCA2 could mimic the conformational
change required by HL5 to bind to a peptide/protein
substrate.
This structural family of enzymes, classed as C14, collectively
exhibits a variety of substrate specificities, activation mechanisms,
potential autoinhibitory machinery and N-terminal functionality.
Structurally, the specificity-diverse caspases and paracaspases
are almost identical whereas the metacaspases have a
different structural topology, and all the family members appear
to use analogous structural elements to recognize and bind their
substrates. Regardless of the diversity exhibited by the family,
it is fair to say that the monomeric forms of these structures
(caspases, paracaspases and type I metacaspases) are all single-
subunit, single-domain monomers, which, in the case of the
caspases and paracaspases, form homodimers. Correspondingly,
the widespread nomenclature that describes this family as
containing a homodimer of heterodimers [3,4], and/or consisting
of small and large subunits [18], may need to be reconsidered.
In addition, this analysis suggests that the metacaspases are
sufficiently structurally and functionally diverse to be classed
separately from the caspases and paracaspases; to investigate
this fully, however, the structure–function relationships for other
available clan CD family members need to be considered.
FAMILY C11: CLOSTRIPAIN
The archetypal member of family C11 is clostripain: a cysteine
peptidase released by the anaerobic bacterium Clostridium
histolyticum. This family of petidases is reportedly found in most
phylogenetic kingdoms but is missing from the Metazoa (see
Table 1). Clostripain is reportedly arginine specific, requiring
Ca2 + for activity and/or stabilization [70]; it needs the loss of
an N-terminal pro-peptide, along with cleavage and removal
of an internal nine-residue peptide, for full activation [71]. To
date, there are no structures of clostripain available in the PDB,
but there is a structure of an unassigned peptidase from family
C11. The Joint Centre for Structural Genomics [72] determined
this structure from the bacterium Parabacteroides merdae, under
the gene name PARMER_00083 (PmC11, see Supplementary
Table S1). The primary sequence of PmC11 is almost 150 residues
shorter than that of clostripain but the two enzymes share a primary
sequence identity of 23% (Clustal Omega [73]).
The structure of PmC11 has a nine-stranded β-sheet with
4↑3↓2↑1↑5↑6↑7↓8↓9↑ topology, in which β1–β2 and β5–β8
overlie well with the six-stranded β-sheet exhibited by the
caspases (Figure 4). Correspondingly, the His133 and Cys179
residues found at the ends of strands β5 and β6 (Hβ3 and Hβ4,
respectively) are likely to be the catalytic dyad. PmC11 also
contains five α-helices, which are structurally homologous to
α1–α5 in the caspases. Apart from its extended β-sheet, PmC11
differs most significantly from the caspases at its C-terminus,
where a further seven α-helices and two β-turns are located after
β8 (Hβ6).
FAMILY C13: LEGUMAIN
The archetypal member of family C13 is legumain, an asparagine-
specific cysteine peptidase, which is found throughout most
phylogenetic kingdoms (see Table 1), although it has been most
extensively studied in the blood fluke parasite Schistosoma sp.,
mammals and plants (in which it was originally identified [74]).
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Legumain is synthesized as an inactive zymogen with the first
17 residues consisting of a signal peptide, which is released
during secretion. Historically, the remainder of the enzyme has
been described as consisting of an eight-residue, N-terminal pro-
peptide, a peptidase domain and a large 110-residue, C-terminal
prodomain. However, the N-terminal region of legumain has
recently been shown to have no role in the activation of the
enzyme [75], whereas the C-terminal domain has been shown to
be instrumental in controlling the zymogen, along with enzyme
activation and stability [9].
Currently, the only structures available from family C13 are
those recently determined for human legumain [9], including the
structure of pro-legumain (peptidase- and C-terminal domains),
along with three structures of the peptidase domain complexed
with the tetrapeptide inhibitor Ac-YVAD-CMK, at pH 7.5
and pH 5.0, and complexed with the peptidomimetic inhibitor
Z-Ala-Ala-AzaAsn-CMK [9] (see Supplementary Table S1).
It is interesting that the peptidase domain of legumain is
topologically equivalent to the caspases and paracaspases,
with a central six-stranded β-sheet and five major α-helices
(see Figure 3D). However, unlike the structurally similar C14
enzymes, legumain is active as a monomer despite no initially
obvious structural reason for prohibiting caspase-like β6–β6′
dimerization.
Legumain is also distinct from all the C14 enzymes, in
that it is activated by pH. Lowering the pH to <5.5 activates
the enzyme, with full peptidase activity at around pH 4.0.
This acidification is accompanied by intermolecular (trans)
autoproteolytic processing at Asn323, a cleavage site situated in
the C-terminal domain. Cleavage is not required for activity
but the reaction rate is much faster when cleavage occurs [76].
In general, legumain exhibits specificity towards asparagine in
P1 (pH optimum 5.5), but at pH 4.5 aspartate is accepted
(and this specificity becomes a preference for aspartate at about
pH 4.0). The functional groups of Arg44 (α1), His45 (α1), Ser216
(L5) and Asp231 (L5) contribute to this specificity, producing a
zwitterionic S1-binding pocket (see Figure 2D), the geometry of
which suggests that Asp231 is protonated at low pH in order to
accept an aspartate in P1 [9].
The structure of pro-legumain revealed that the C-terminal
domain (C domain) is organized into two distinct parts:
an activation peptide (AP, positioned immediately after the
peptidase domain) and a C-terminal DD-like fold, consisting
of five α-helices, denoted as LSAM (legumain stabilization and
activity modulation) domain [9]. Both the AP and the LSAM
domains interact extensively with the peptidase domain at the
autoprocessing site Asn323 found at the interface between them.
In addition, Ser307 from the AP forms hydrogen bonds to Arg44
and Ser216 in the P1 pocket, blocking access to the active site.
The interacting surfaces of the C domain and the peptidase
domain are complementary (positively and negatively charged,
respectively) and, as the pH is lowered and the peptidase
becomes protonated, the interaction between the two surfaces
is disrupted (in particular several salt bridges), which produces a
conformational arrangement that allows substrates to access the
active site. However, the C domain does not dissociate from the
enzyme on processing; in fact it becomes markedly unstable if
the LSAM domain is removed [9] and it is not possible to express
legumain in the absence of the C domain [75]. Furthermore,
superimposing a copy of pro-legumain on to each monomer
in the caspase-7 dimer reveals a steric clash between LSAM
domains. This, together with the fact that there is no biological
need for dimerization, suggests that monomeric legumain is a
more energetically favourable form. In summary, a change in
pH (the activation mechanism), followed by trans-autoprocessing
and a conformational rearrangement, has a role in producing fully
mature legumain.
FAMILY C25: GINGIPAIN
The only structure available from the C25 family of clan CD
peptidases is gingipain R (RgpB), a virulence factor participating
in the infection and survival of Porphyromonas gingivalis in
periodontitis. To date, the RgpB structure has been determined
in both its mature and its pro-forms [13,14] (see Supplementary
Table S1). The crystal structure of the mature form of RgpB
revealed a monomeric enzyme with a central 10-stranded β-
sheet, which is the largest central β-sheet of all the clan CD
structures determined to date [13]. Similar to other clan
CD structures, the central sheet is surrounded on both sides by
β-hairpins and several α-helices. Consideration of the structure in
the same orientation as the caspases reveals that the sheet exhibits
6↑5↑7↑8↑9↑10↓4↓3↓1↓2↓ topology, resulting in an internal quasi-
symmetry situated between strands 9 and 10. However, the four
N-terminal strands (β1–β4) are twisted out of the plane of the
other strands by about 45◦, and are often, perhaps best described as
a separate N-terminal subdomain (NSD) [13,14]. The C-terminal
subdomain (CSD [14]), encompassing strands β5–β10, overlies
well with the structure of caspase-7, including the position of the
caspase helices α1–α4 (helices H1–H4, see Figure 3). The SSEs
in the CSD are named in line with the caspase nomenclature (as
described for the metacaspases above), e.g. RgpB β5 is described
as Hβ1 (strand H1, see Figure 3E). The last 84 C-terminal residues
after β10 (Hβ6) form an IgSF (Ig superfamily) domain.
RgpB exhibits an exclusive specificity for arginine in P1 and
the original structure of RgpB was reported complexed with the
peptide inhibitor D-FFR-CMK [13]. Analysis of the active site
revealed that, similar to other members of clan CD, the catalytic
histidine/cysteine dyad (His221/Cys244) in RgpB is found at the C-
terminal ends of Hβ3 and Hβ4, respectively. In addition, residues
forming hydrogen bonds to the P1 arginine are Asp163 (Hα1), Gly210
(L3), Gly212 (L3), Gln282 (HL5), and Trp284 (HL5) (Figure 2E). Trp284
is also found stacking on top of the P1 arginine covering the S1
pocket like a lid. It is interesting that the only functional group
involved in hydrogen bonding to the P1 arginine is the carboxylic
acid of Asp163, which forms a stable bidentate salt bridge with the
guanidino group.
The pro-form of RgpB consists of a 229-residue, N-terminal
prodomain, which contains two autoprocessing sites at Arg126
and Arg229 (proform numbering denoted PArg126 and PArg229,
respectively). Cleavage at these sites is required for full activation
of the enzyme [77], with cleavage at PArg126 being essential for
processing at PArg229 and subsequent removal of the prodomain.
Despite this requirement for full activation, a PR126A/PR229A
mutant enzyme was found to exhibit some latent activity, albeit
80-fold lower than that of the mature enzyme [77]. Recently,
the crystal structure of the inactive RgpB complexed with
its prodomain was determined (see Supplementary Table S1),
revealing the largest structurally classified prodomain in clan CD
to date [14].
This structure revealed that a loop on the prodomain (termed
the ‘inhibitory loop’) runs towards the S1-binding pocket, injects
PArg126 into the pocket, and loops back at this point. This mimics
the P1 arginine of a bound substrate, with the guanidino group
overlying in an identical fashion to that of the bound inhibitor.
Similar to the P1 arginine of the bound inhibitor, PArg126 makes
a bidentate salt bridge with Asp163 in the mature enzyme but
in addition it makes a strong hydrogen bond with His221. This
appears to cause PArg126 to rotate away from the catalytic cysteine,
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with the resulting position being unfavourable for cleavage to
occur. However, it is at this position that the initial cleavage
for complete activation of RgpB takes place. Of interest, there
are very few changes between the structures of the inhibited
and the prodomain complexes, suggesting that the zymogen is
in a favourable conformation for activity and inhibition by the
prodomain is most probably mediated by a competing substrate
[14]. However, the mechanism for prodomain dissociation in vivo
is still unknown.
It is well documented that Rgps are stabilized by calcium and
inhibited by EDTA [78] and superimposing the prodomain and
inhibitor-bound structures reveals three distinct Ca2+ binding sites,
which are highly conserved between the two structures. Two of
these are found near important substrate-binding regions (HL4
and beneath the S1-binding pocket). The importance of the third
site is less obvious but it does involve Asp103 and Glu107, which
form hydrogen bonds with the prodomain in the structure of the
zymogen. It has not been reported whether any of these sites is
critical in the activation of the enzyme, but they do all appear to
have a role in the structural stability of RgpB with and without
the prodomain.
FAMILY C80: MARTX-CPD
The first structure available for family C80 was that of the
CPD from the multi-functional autoprocessing repeats in toxin
(MARTX) toxin from the pathogenic bacterium Vibrio cholerae.
MARTX is an unusually large toxin (>450 kDa), which is secreted
by the bacterium, causing disassembly of the actin cytoskeleton,
and subsequent bacterial colonization, of the small intestine [79].
The N- and C-terminal regions of the toxin have large sections
of conserved repeats with only the central region (about 1700
residues) containing the effector domains which are thought
to impart distinct functions to the toxin. One such domain is
the CPD, activity of which is required for activation of the
toxin in eukaryotic cells [80], via CPD-mediated proteolysis
of regions between the various effector domains, to release
them [81]. MARTX-CPD itself is activated by myo-inositol
hexakisphosphate (InsP6), a molecule present in the cytosol of
eukaryotic cells but absent in the bacterium, hence the activation
and subsequent processing of the toxin would not occur until after
translocation into the host.
In addition to V. cholerae MARTX toxin, the CDP
domains of Clostridium difficile toxins A and B (TcdA and
TcdB, respectively) have also been determined [16,17] (see
Supplementary Table S1). These enzymes are also activated
by InsP6 and similarly require CDP-mediated autoprocessing to
allow for overall toxin function [82,83]. The structure of MARTX-
CPD contains a seven-stranded β-sheet with 3↓2↑1↑4↑5↑6↓7↓
topology, which is surrounded by three major α-helices (see
Figure 3F). The structures of TcdA-CPD and TcdB-CPD are
topologically identical to each other and very similar to the
structure of MARTX-CPD, which shares 93% of its SSEs with
TcdA-CPD (PDBefold [66]). However, the structures of the C.
difficile CPDs contain a nine-stranded β-sheet with an extra strand
flanking both ends of the MARTX-CPD sheet, giving an overall
topology of 4↑3↓2↑1↑5↑6↑7↓8↓9↑; this is the same as observed for
PmC11 (see Figure 4).
The structure of MARTX-CPD has been determined in its an
apo- [15], inhibitor-bound [81] and pre-processed forms [84] (see
Supplementary Table S1) – and together these structures provide
a fascinating insight into the unusual activation mechanism of
the peptidase. Consequently, this enzyme is used for further
structural analysis. In MARTX-CPD, strands β1–β2 and β4–
β7 overlie reasonably well with the six-stranded β-sheet found in
the caspases, with β3 sitting on the outside of this core structure
(see Figure 3F). In addition, a β-hairpin loop (βA–βC), termed
the ‘β-flap’ [15], is located between Hβ5 and Hβ6. Spatially, this
replaces α4 and α5 in the caspases and other clan CD members
(see Figure 3) and forms a cleft in which InsP6 is found.
MARTX-CPD and TcdA/B-CPDs all have a strict specificity
for leucine in P1 [81], and consequently family C80 is the only
family in clan CD, reported to date, that has a preference for a
hydrophobic substrate (see Table 2). The first step in the CPD-
mediated proteolytic activation of the MARTX toxin [15] is
intramolecular autoprocessing of the CPD itself. This internal
cleavage occurs at a leucine residue found 30 residues N-terminal
to β1 (Leu0-Ala1 [15], P1–P1) and occurs only after activation
of MARTX-CPD by InsP6. In the structure of the inactive and
unprocessed form of MARTX-CPD, Leu0 is found anchored in
the large hydrophobic S1-binding pocket, occupying the same
position as the P1 leucine in the inhibitor (Z-LLL-EP-COO-Et)-
bound structure [81] (see Supplementary Table S1).
The catalytic dyad (His91 and Cys140) is found at the C-terminal
ends of Hβ3 and Hβ4, and a total of seven hydrophobic residues lie
within van der Waals’ bond distance (4.4 Å) of the P1 leucine [81]:
Ala47 (α1); Gly89–Val90 (HL3); Val138–Gly139 (HL4); and Leu175–
Ala176 (βA, HL5β1) (see Figure 2F). In all crystal structures of
MARTX-CPD an InsP6 molecule is found bound by 13 residues,
in a large basic pocket structurally segregated from the S1-binding
pocket. Notably, both the S1- and InsP6-binding pockets contain
residues from distinct regions on the β-flap, with βA and βB
contacting the P1 leucine and InsP6, respectively.
It has been shown, in the pre-processed form of MARTX-CPD,
that Leu0 occupies the S1-binding site (presumably controlling
the latent activity) irrespective of InsP6 binding, but not in a
way amenable to intramolecular processing; for this InsP6 is
required [84]. Binding of InsP6 causes a movement in βB, which
is communicated to the hydrophobic S1 residues on βA (via the β-
flap), resulting in Leu0 becoming more tightly bound in the active
site [84]. The outcome of this is that the orientation of the scissile
bond in Leu0, relative to the catalytic cysteine, becomes amenable
to cis-cleavage. After InsP6-activated processing, the CPD loses
its high affinity for the InsP6 molecule and is thought to release
it. Reoccupation of the S1 site by a new substrate is thought
to reactivate the InsP6-binding affinity and hence the proteolytic
activity of MARTX-CPD.
CLAN CD COMPARISON
Overview
The caspases are the original structural family in clan CD and,
despite growth in structural knowledge for other clan CD families,
they remain a sensible structural archetype. This is supported by
the fact that many of the SSEs found in the caspases are present in
other family members. Indeed, all members of clan CD contain the
six-stranded β-sheet exhibited by the caspases [with five parallel
and one antiparallel strand(s)], with the catalytic histidine/cysteine
dyad found at the C-terminal ends of Hβ3 and Hβ4, respectively
(see Figures 2 and 3). In addition, all members, with the exception
of MARTX-CPD (and the other C80 family members), share five
structurally conserved α-helices (Hα1–Hα5) (see Figure 3). This
is emphasized by aligning the structures from all the other clan
CD families with the caspases (using caspase-7 as a template) and
obtaining a measure of structural similarity (PDBeFold [66], as
described above).
In terms of similarity to the caspases, the Q score reveals
that MALT1-P is more similar than (>) legumain > TbMCA2
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> PmC11 > gingipain > MARTX-CPD. The alignment also
shows that 67–87% of the SSEs of caspase-7 can be identified
in all other family members, apart from those found in family
C80, which shares only 47% of its SSEs with caspase-7, and
vice versa (see Table 3). It is interesting to note that caspase-
7 shares more of its SSEs (87%) with legumain than with any
other family member, making the caspases significantly more
structurally similar to legumain than to the metacaspases. This
analysis also revealed that MALT1-P (C14B) is more structurally
similar to caspase-7 (C14A) than any of the other structures in
the clan (see Table 3). The structural differences of legumain,
MALT1-P and the caspases are rather subtle, whereas the other
families, with much longer central β-sheets, share far fewer of
their SSEs with the caspases (from 47% to 32%) (see Table 3).
Indeed, the basic topology of the central β-sheets differs in
all the families apart from those represented by the caspases,
paracaspases and legumain (see Figure 4).
Comparing all the structural families with each other reveals
that more of the SSEs in PmC11, legumain, RgpB and MARTX-
CPD are found in the caspases than in any of the other structures
(see Supplementary Table S2), i.e. none of these families shares
more SSEs with each other than with the caspases. However,
more of the SSEs in TbMCA2 can be identified in MALT1-
P and legumain than caspases, whereas MALT1-P shares the
same number of SSEs with both caspase-7 and legumain (see
Supplementary Table S2a). Comparison of just the Q scores
reveals that no two families are more structurally similar to each
other than to the caspases, confirming that at a basic level all
these structures share basic structural elements with the caspases
(see Supplementary Table S2b). However, this scoring method
considers only the parts of the structures that align and does not
take into account gaps in the alignment, which would account for
potentially important deletions and insertions.
Using an adaptation of the Q score, known as QH (a measure of
structural homology) [85], that takes into account these alignment
gaps, a more accurate representation of structural homology can
be calculated. To calculate the QH scores, a STAMP [86] multiple
structural alignment was carried out on all the families represented
by clan CD, using the molecular visualization program VMD
[87]. The differences in QH values were derived from the
structural alignment and a phylogenetic tree based on these values
was produced to depict a structural evolution of the clan (see
Figure 4). This phylogenetic tree (based on structure) suggests that
legumain, the caspases, the paracaspases and the metacaspases
are all more closely related in structure to each other than to
the other families in the clan. However, although the caspases
and paracaspases are found on the same branch of the tree, both
legumain and the metacaspases are found on different, distinct
branches. This tree also suggests that PmC11 and MARTX-CDP
sit on the same branch, distinct from the caspase group, and that
RgpB represents the most structurally distinct family.
S1-binding sites
In general, the families found in clan CD exhibit individual and
rather strict substrate specificities, with a preference for basic
residues in P1 being the most common (see Table 2). Five of the
families in clan CD have been determined as complexes with
peptide inhibitors – no complex structures are currently available
for the metacaspases or PmC11. Mapping the residues involved
in substrate binding on to the structures allowed the residues and
SSEs in the S1-binding pockets to be determined and compared.
In the caspases, substrate recognition has been well studied
and is known to depend on three highly conserved side chains
from Arg87, Gln184 and Arg233 (caspase-7 nomenclature) that
are responsible for creating a basic environment for binding an
aspartate residue on P1. These residues are found on loops L1, L4
and L5 (the last of which forms a short section of β-sheet with
the bound inhibitor), respectively. In MALT1, acidic aspartate and
glutamate residues [Asp365 (α1), Asp462 (L4) and Glu500 (L5)] are
found in similar structural positions, respectively (see Figures 2A
and 2B). Although a functionally specific Glu500 in MALT1 is
found to overlie with Arg233 in caspase-7 (opposite charges,
opposite binding specificities), no such charged residues are found
in this position in the topologically equivalent legumain. It is
interesting, however, that, although legumain does not appear to
have a functional substrate-binding residue on L5, the guanidino
group from Arg44 on α1 overlies in almost exactly the same way
in Arg233, despite the fact that the Cα positions are found on
markedly different parts of the structures. Notably, for all the
structures analysed, S1 specificity in clan CD can be attributed
solely to three main structural regions – (H)α1 [(H)L1], (H)L4 and
(H)L5 – and these all appear to contribute to a correctly charged
P1-binding environment. Analysis of the S1-binding pockets of
the various families also reveals a conserved aromatic residue
on (H)L5 (see Figure 2), which forms hydrophobic contacts with
the bound inhibitors (see Supplementary Figure S1) and may be
important for directing substrates into the S1 pocket.
By looking at the structural regions forming hydrogen bonds
and hydrophobic contacts to the inhibitors in the P2–P4 positions
(in addition to P1), it becomes obvious that: the regions involved
in the S1- to S4-binding pockets in clan CD are (H)L1, (H)α1, (H)L3,
(H)L4, (H)L5, (H)α4 and (H)L6; and, along with the histidine/cysteine
dyad, a glycine residue adjacent to the catalytic histidine is also
structurally conserved in all families. Mapping of these regions
may allow the substrate-binding residues in other, ligand-free,
structures to be predicted. Indeed, mapping of the residues known
to be important for activity in TbMCA2 on to the SSEs in the
structure reveals that these residues are found on α1, L3 and L4.
However, (H)L5, which is important for binding in all the complex
structures, is disordered in TbMCA2, although it exhibits a shift in
the presence of Ca2 + [11], suggesting that it will, most probably,
be involved in substrate binding in the metacaspases. MARTX-
CPD is somewhat different to the other family members and its
substrate-binding regions are similar but not quite as conserved
as those of the other families. However, even when the SSE in
MARTX-CPD has changed from an α-helix to a β-strand (in the
case of βA and Hα4), the interacting residues in the different
families are spatially equivalent. Subsequently, all ligand-binding
regions in clan CD are found in parts of the structure that overlie
well with the caspases, in front or on top of the β-sheet, as shown
in Figures 2 and 3.
Pro-forms
The structures of the clan CD enzymes reveal that they
often contain diverse N-terminal and/or C-terminal (prodomain)
regions. With the exception of PmC11, data are available for the
N-terminal regions for all the families. In the case of the initiator
and inflammatory caspases, the large N-terminal regions contain
important CARD or DED domains, whereas the effector caspases
have short N-terminal regions for which the function is less well
defined. It is difficult to ascertain whether the N-terminal regions
in the effectors are true prodomains (as they are often described)
because emerging research is starting to suggest that their removal
is not necessary for activation; in contrast, however, they do appear
to have a part to play in enzyme inhibition. In addition, these
regions have eluded structural determination, suggesting that they
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are not strongly bound to the surface of the caspase. This is rather
different to the N-terminal regions found in TbMCA2, RgpB
and MARTX-CPD, in which structures determined with the N-
terminal regions present revealed that they formed a considerable
number of hydrogen bonds on the surface of the peptidase domain.
In addition to binding to the surface of the protease, the N-
terminal region in TbMCA2 was found to obstruct the active
site by forming hydrogen bonds with residues in the S1-binding
pocket. Similarly, the N-terminal domain of RgpB injects a
residue into the active site, forming a salt bridge with the residue
responsible for substrate specificity in P1, and in the MARTX-
CPD the N-terminal region is found to hydrogen bond to the
catalytic cysteine. It is also of interest that, although MALT1 is
a large complex with a DD and two Ig-like domains sitting N-
terminal to the paracaspase, the apo-form of the enzyme also
exhibits an active site obstruction from a residue situated on
one of the substrate-binding loops. In addition, although the
structure of the N-terminal region of legumain (about 25 residues)
is not available, an ordered C-terminal domain is present in the
structure of the zymogen [9], which has extensive interactions
with the peptidase domain (PDBePisa [88]) and also blocks the
S1-binding pocket.
This suggests that all these families exhibit some level of
proteolytic inhibition until they need to function as active
peptidases. In the case of TbMCA2, MALT1 and MARTX-
CPD, it is known that ‘inhibitory’ sections of the enzymes do
not dissociate from the peptidase on activation, but an obvious
movement in these sections is required before substrate binding.
It is possible that there is a similar mechanism in some of the
effector caspases. Unusually for the clan, the N-terminal domain
of RgpB dissociates from the main body of the enzyme and,
although the mechanism for this is not entirely understood, it
is most probably due to a competing substrate in the presence of
Ca2 + . With the exception of the caspases, structures of the inactive
forms of other families in clan CD exhibit N- or C-terminal regions
that block access to their active sites. It appears that the catalytic
machinery in these enzymes is preformed, but the N- or C-terminal
domain/regions sterically block substrate access, and a movement
and/or cleavage in these regions is required for substrate
binding.
Activation mechanisms
Dimerization
The activation mechanisms for clan CD family members are
reasonably diverse (see Table 2). One is dimerization. Activation
by dimerization is required by several members of family
C14, and the initiator and inflammatory caspases and MALT1
are all activated by this mechanism. In addition, the effector
caspases are active only as dimers, although they exist in cells
as inactive zymogens, so dimerization, although required, is not
their activation mechanism. All the other family members of clan
CD studied to date are active as monomers.
Internal processing
Another method of peptidase activation exhibited by clan CD
enzymes is proteolysis. The effector caspases are activated by
cleavage on L4 – a loop region internal to the β-sheet, which is
required for the correct formation of the active site. This cleavage
became a defining structural feature of the archetypal members of
clan CD, resulting in the caspases (along with the metacaspases
and paracaspases) being (wrongly) described as composed of two
subunits (large and small; before and after the cleavage site).
Indeed, the effector caspases are the only group in clan CD for
which cleavage of a loop region within the central β-sheet is
required for activation or maturation; even structurally conserved
MALT1-P and legumain have no known cleavage sites on L4
or within the peptidase domain. However, this is not to say that
proteolysis is not important in the activation of clan CD enzymes:
legumain, RgpB and MARTX-CPD all require cleavage, at
sites external to their central β-sheets, for full activation to
occur.
Ligand/pH change
Other activation mechanisms of clan CD enzymes include changes
in pH (legumain) and the addition of ligands (InsP6: MARTX-
CPD, and Ca2+: metacaspases and RgpB). The pH change and
allosteric binding of InsP6 in legumain and MARTX-CPD,
respectively, both result in movement around the sterically
blocked active sites of the pro-forms which allows subsequent
processing and/or substrate access. Less is known about the
order of proteolysis and Ca2+ binding in RgpB, but there are no
reports of enzyme activity with no Ca2+ present. It is interesting
that the three Ca2+-binding sites identified in RgpB are not
structurally conserved with the single site identified in TbMCA2.
The location of two of the Ca2+-binding sites in RgpB suggests
that they may contribute to the stability of the active site, although
the third binds to residues on the protease that are involved in
hydrogen bonding with the prodomain. The residues around the
Ca2+-binding site in TbMCA2 are also involved in salt-bridge
formation, with the N-terminal region, and it is intriguing to
assume that Ca2+ could disrupt interactions of the inhibitory
regions, producing (or allowing for) the conformational change
required for substrate access.
CONCLUSION
In conclusion, clan CD cysteine peptidases are a diverse group
of enzymes found throughout the entire phylogenetic kingdom,
exhibiting a wide range of functions, specificities and activation
mechanisms. Structurally, they all contain a central β-sheet with a
minimum of six strands (five parallel and one antiparallel) and are
surrounded by various structural elements including a number of
conserved α-helices. Substrate binding and specificity in the clan
can be attributed to a few structurally homologous regions and
the activity of many of the enzymes is self-regulated, to prevent
undesirable proteolysis, through autoinhibitory mechanisms. The
basic topology of the caspases (C14A), paracaspases (C14B) and
legumain (C13) have been shown to be identical, whereas the
topology of the metacaspases (C14B) is quite different, suggesting
that metacaspases have been placed in the wrong structural family
and adding to the opinion that metacaspases are not caspases
[47,89] after all.
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